Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Steve Waqanivavalagi

Showing results (1-10 of 5) with videos related to

Pageof 1
Sort By:
Emergency Medicine Australasia : EMA|October 6, 2020
Eligibility criteria for extracorporeal cardiopulmonary resuscitation at Auckland City Hospital: A retrospective cohort studyMichael Iwashita, Steve Waqanivavalagi, Tobias Merz, et al.
Acta Biomaterialia|June 3, 2021
Models of immunogenicity in preclinical assessment of tissue engineered heart valvesMarcus Ground, Steve Waqanivavalagi, Robert Walker, et al.
Plos One|June 17, 2022
Fibroblast growth factor 2 inhibits myofibroblastic activation of valvular interstitial cellsMarcus Ground, Steve Waqanivavalagi, Young-Eun Park, et al.
Journal of Molecular and Cellular Cardiology|November 3, 2022
Generating robust human valvular interstitial cell cultures: Protocol and considerationsMarcus Ground, Young Eun Park, Steve Waqanivavalagi, et al.
The New Zealand Medical Journal|October 14, 2016
Pilot study of feasibility of a randomised controlled trial of asthma risk with paracetamol versus ibuprofen use in infancyJudith Riley, Anna Hunt, Alice McDouall, et al.
Pageof 1

Showing results (1-10 of 5) with videos related to

Sort By:
Pageof 1
Emergency Medicine Australasia : EMA|October 6, 2020
Eligibility criteria for extracorporeal cardiopulmonary resuscitation at Auckland City Hospital: A retrospective cohort studyMichael Iwashita, Steve Waqanivavalagi, Tobias Merz, et al.
Acta Biomaterialia|June 3, 2021
Models of immunogenicity in preclinical assessment of tissue engineered heart valvesMarcus Ground, Steve Waqanivavalagi, Robert Walker, et al.
Plos One|June 17, 2022
Fibroblast growth factor 2 inhibits myofibroblastic activation of valvular interstitial cellsMarcus Ground, Steve Waqanivavalagi, Young-Eun Park, et al.
Journal of Molecular and Cellular Cardiology|November 3, 2022
Generating robust human valvular interstitial cell cultures: Protocol and considerationsMarcus Ground, Young Eun Park, Steve Waqanivavalagi, et al.
The New Zealand Medical Journal|October 14, 2016
Pilot study of feasibility of a randomised controlled trial of asthma risk with paracetamol versus ibuprofen use in infancyJudith Riley, Anna Hunt, Alice McDouall, et al.
Pageof 1